Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Point72 Asset Management, L.P. reported a 5.90% stake in Dianthus Therapeutics, Inc. (Schedule 13G)
Event Apr 10, 2025 · Filed Apr 17, 2025
Point72 Asset Management, L.P. reported a 5.90% stake in Dianthus Therapeutics, Inc., 1,894,304 shares, as a passive investor on Apr 10, 2025. Filed Apr 17, 2025 (Schedule 13G).
- Stake
- 5.90%
- Shares
- 1,894,304
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.90% | 1,894,304 |
| Point72 Capital Advisors, Inc. | 5.90% | 1,894,304 |
| Steven A. Cohen | 5.90% | 1,894,304 |
Source
Related
- Dianthus Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Sep 12, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2025
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026